Solara Active Pharma Sciences has confirmed that the Company does not fall under the criteria of Large Corporate as per the applicability criteria given under the SEBI/ HO/ DDHS/ CIR/ P/ 2018/ 144 dated November 26, 2018. Accordingly, the Company is exempt from Annual Disclosure requirement as mentioned in the aforesaid circular for the financial year 2022-2023.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1681.15 |
| Dr. Reddys Lab | 1223.50 |
| Cipla | 1239.75 |
| Zydus Lifesciences | 945.55 |
| Lupin | 2315.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: